Dallas, TX, United States of America

Daolin Tang

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daolin Tang. Retrieved from https://idiyas.com/inventor/daolin-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daolin Tang: Innovator in Inflammatory Response Treatment

Introduction

Daolin Tang is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of medical treatments, particularly in addressing conditions involving elevated inflammatory responses. His innovative approach has the potential to impact patient care positively.

Latest Patents

Daolin Tang holds 1 patent for his work titled "Methods of treating conditions involving elevated inflammatory response." This patent outlines a method for treating patients with elevated inflammatory responses, such as those experiencing sepsis. The method involves administering an inhibitor of anaplastic lymphoma kinase (ALK inhibitors) or expression of ALK to effectively manage the elevated inflammatory response.

Career Highlights

Daolin Tang is affiliated with the University of Pittsburgh, where he continues to advance his research and innovations. His work is characterized by a commitment to improving treatment methodologies for serious medical conditions.

Collaborations

Daolin Tang collaborates with esteemed colleagues, including Ling Zeng and Timothy R Billiar. Their combined expertise enhances the research and development of effective treatment strategies.

Conclusion

Daolin Tang's contributions to the field of medical treatment for inflammatory responses exemplify the impact of innovative thinking in healthcare. His patent and ongoing research hold promise for improving patient outcomes in critical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…